{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:23:59Z","timestamp":1792567439127,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T00:00:00Z","timestamp":1262649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00223-009-9327-6","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T05:17:57Z","timestamp":1262582277000},"page":"132-141","source":"Crossref","is-referenced-by-count":31,"title":["Hyperhomocysteinemia Due to Levodopa Treatment as a Risk Factor for Osteoporosis in Patients with Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"86","author":[{"given":"Seung Hun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Reul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sail","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sook","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghi Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Chong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"9327_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ageing\/21.1.32","volume":"21","author":"O Johnell","year":"1992","unstructured":"Johnell O, Melton LJ 3rd, Atkinson EJ, O\u2019Fallon WM, Kurland LT (1992) Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 21:32\u201338","journal-title":"Age Ageing"},{"key":"9327_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jama.1982.03320290053035","volume":"247","author":"JF Aita","year":"1982","unstructured":"Aita JF (1982) Why patients with Parkinson\u2019s disease fall. JAMA 247:515\u2013516","journal-title":"JAMA"},{"key":"9327_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00002826-198904000-00003","volume":"12","author":"WC Koller","year":"1989","unstructured":"Koller WC, Glatt S, Vetere-Overfield B, Hassanein R (1989) Falls and Parkinson\u2019s disease. Clin Neuropharmacol 12:98\u2013105","journal-title":"Clin Neuropharmacol"},{"key":"9327_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(00)00458-5","volume":"182","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kaji M, Tsuru T, Oizumi K (2001) Risk factors for hip fracture among elderly patients with Parkinson\u2019s disease. J Neurol Sci 182:89\u201393","journal-title":"J Neurol Sci"},{"key":"9327_CR5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jbspin.2004.04.012","volume":"72","author":"N Vaserman","year":"2005","unstructured":"Vaserman N (2005) Parkinson\u2019s disease and osteoporosis. Joint Bone Spine 72:484\u2013488","journal-title":"Joint Bone Spine"},{"key":"9327_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00006231-199403000-00010","volume":"15","author":"CH Kao","year":"1994","unstructured":"Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH (1994) Bone mineral density in patients with Parkinson\u2019s disease measured by dual photon absorptiometry. Nucl Med Commun 15:173\u2013177","journal-title":"Nucl Med Commun"},{"key":"9327_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/24.4.326","volume":"24","author":"H Taggart","year":"1995","unstructured":"Taggart H, Crawford V (1995) Reduced bone density of the hip in elderly patients with Parkinson\u2019s disease. Age Ageing 24:326\u2013328","journal-title":"Age Ageing"},{"key":"9327_CR8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.49.5.1273","volume":"49","author":"Y Sato","year":"1997","unstructured":"Sato Y, Kikuyama M, Oizumi K (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson\u2019s disease. Neurology 49:1273\u20131278","journal-title":"Neurology"},{"key":"9327_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archinte.166.1.88","volume":"166","author":"CG Gjesdal","year":"2006","unstructured":"Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, Tell GS (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88\u201394","journal-title":"Arch Intern Med"},{"key":"9327_CR10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bone.2004.04.018","volume":"35","author":"J Golbahar","year":"2004","unstructured":"Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR (2004) Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 35:760\u2013765","journal-title":"Bone"},{"key":"9327_CR11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2005.04.017","volume":"37","author":"MS Morris","year":"2005","unstructured":"Morris MS, Jacques PF, Selhub J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:234\u2013242","journal-title":"Bone"},{"key":"9327_CR12","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","volume":"350","author":"RR McLean","year":"2004","unstructured":"McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042\u20132049","journal-title":"N Engl J Med"},{"key":"9327_CR13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","volume":"350","author":"JB Meurs van","year":"2004","unstructured":"van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033\u20132041","journal-title":"N Engl J Med"},{"key":"9327_CR14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.amjmed.2005.01.052","volume":"118","author":"Y Sato","year":"2005","unstructured":"Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson\u2019s disease. Am J Med 118:1250\u20131255","journal-title":"Am J Med"},{"key":"9327_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00969090","volume":"18","author":"R Benson","year":"1993","unstructured":"Benson R, Crowell B, Hill B, Doonquah K, Charlton C (1993) The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance. Neurochem Res 18:325\u2013330","journal-title":"Neurochem Res"},{"key":"9327_CR16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/mds.20253","volume":"19","author":"PE O\u2019Suilleabhain","year":"2004","unstructured":"O\u2019Suilleabhain PE, Bottiglieri T, Dewey RB Jr, Sharma S, Diaz-Arrastia R (2004) Modest increase in plasma homocysteine follows levodopa initiation in Parkinson\u2019s disease. Mov Disord 19:1403\u20131408","journal-title":"Mov Disord"},{"key":"9327_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","volume":"60","author":"JD Rogers","year":"2003","unstructured":"Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R (2003) Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol 60:59\u201364","journal-title":"Arch Neurol"},{"key":"9327_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9327_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"9327_CR20","first-page":"153","volume-title":"Recent developments in Parkinson\u2019s disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton R (1987) Unified Parkinson\u2019s Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds) Recent developments in Parkinson\u2019s disease. Macmillan Health Care Information, New York, pp 153\u2013163"},{"key":"9327_CR21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jocd.2006.05.002","volume":"9","author":"N Binkley","year":"2006","unstructured":"Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM (2006) Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom 9:4\u201314","journal-title":"J Clin Densitom"},{"key":"9327_CR22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.5650100719","volume":"10","author":"D Kiel","year":"1995","unstructured":"Kiel D (1995) Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 10:518\u2013523","journal-title":"J Bone Miner Res"},{"key":"9327_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"9327_CR24","first-page":"671","volume":"26","author":"DK Lee","year":"2005","unstructured":"Lee DK, Choi HK, Son JC, Chung WJ, Kim BT, Kim K (2005) Serum homocysteine and its relevant factors among health screeners in a university hospital. J Korean Acad Fam Med 26:671\u2013679","journal-title":"J Korean Acad Fam Med"},{"key":"9327_CR25","first-page":"1","volume":"37","author":"SH Mudd","year":"1985","unstructured":"Mudd SH, Skovby F, Levy HL et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1\u201331","journal-title":"Am J Hum Genet"},{"key":"9327_CR26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","volume":"293","author":"Y Sato","year":"2005","unstructured":"Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082\u20131088","journal-title":"JAMA"},{"key":"9327_CR27","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/archinte.167.19.2136","volume":"167","author":"AM Sawka","year":"2007","unstructured":"Sawka AM, Ray JG, Yi Q, Josse RG, Lonn E (2007) Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch Intern Med 167:2136\u20132139","journal-title":"Arch Intern Med"},{"key":"9327_CR28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0140-6736(91)92782-W","volume":"338","author":"WS Browner","year":"1991","unstructured":"Browner WS, Malinow MR (1991) Homocyst(e)inaemia and bone density in elderly women. Lancet 338:1470","journal-title":"Lancet"},{"key":"9327_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0925-4439(95)00119-0","volume":"1315","author":"B Lubec","year":"1996","unstructured":"Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick\u2019s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159\u2013162","journal-title":"Biochim Biophys Acta"},{"key":"9327_CR30","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1373\/clinchem.2005.053363","volume":"51","author":"M Herrmann","year":"2005","unstructured":"Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W (2005) Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 51:2348\u20132353","journal-title":"Clin Chem"},{"key":"9327_CR31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1359\/jbmr.060406","volume":"21","author":"JM Koh","year":"2006","unstructured":"Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003\u20131011","journal-title":"J Bone Miner Res"},{"key":"9327_CR32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bone.2006.03.004","volume":"39","author":"DJ Kim","year":"2006","unstructured":"Kim DJ, Koh JM, Lee O, Kim NJ, Lee YS, Kim YS, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 39:582\u2013590","journal-title":"Bone"},{"key":"9327_CR33","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.apmr.2006.07.265","volume":"87","author":"M Di Monaco","year":"2006","unstructured":"Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A (2006) Bone mineral density in hip-fracture patients with Parkinson\u2019s disease: a case-control study. Arch Phys Med Rehabil 87:1459\u20131462","journal-title":"Arch Phys Med Rehabil"},{"key":"9327_CR34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/clinchem\/47.6.1102","volume":"47","author":"F Blandini","year":"2001","unstructured":"Blandini F, Fancellu R, Martignoni E, Mangiagalli A, Pacchetti C, Samuele A, Nappi G (2001) Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. Clin Chem 47:1102\u20131104","journal-title":"Clin Chem"},{"key":"9327_CR35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","volume":"60","author":"JW Miller","year":"2003","unstructured":"Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG, Wolf PA (2003) Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 60:1125\u20131129","journal-title":"Neurology"},{"key":"9327_CR36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2008-1777","volume":"94","author":"MS Leboff","year":"2009","unstructured":"Leboff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S (2009) Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 94:1207\u20131213","journal-title":"J Clin Endocrinol Metab"},{"key":"9327_CR37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254\u20131259","journal-title":"BMJ"},{"key":"9327_CR38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","volume":"72","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72:S1\u2013S136","journal-title":"Neurology"},{"key":"9327_CR39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","volume":"332","author":"SC Manolagas","year":"1995","unstructured":"Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305\u2013311","journal-title":"N Engl J Med"},{"key":"9327_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/art.1780390111","volume":"39","author":"H Burger","year":"1996","unstructured":"Burger H, van Daele PL, Odding E, Valkenburg HA, Hofman A, Grobbee DE, Schutte HE, Birkenhager JC, Pols HA (1996) Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study. Arth Rheum 39:81\u201386","journal-title":"Arth Rheum"},{"key":"9327_CR41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","volume":"81","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81:153\u2013161","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-009-9327-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9327-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T12:25:42Z","timestamp":1711110342000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-009-9327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9327"],"URL":"https:\/\/doi.org\/10.1007\/s00223-009-9327-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,5]]}}}